Bank of New York Mellon’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.1M Sell
790,756
-313,136
-28% -$4.38M ﹤0.01% 1840
2025
Q1
$15M Sell
1,103,892
-139,095
-11% -$1.89M ﹤0.01% 1642
2024
Q4
$25.3M Sell
1,242,987
-87,364
-7% -$1.78M ﹤0.01% 1428
2024
Q3
$38.8M Sell
1,330,351
-209,920
-14% -$6.11M 0.01% 1193
2024
Q2
$35.8M Sell
1,540,271
-237,636
-13% -$5.52M 0.01% 1226
2024
Q1
$36.5M Sell
1,777,907
-92,720
-5% -$1.9M 0.01% 1230
2023
Q4
$40.1M Sell
1,870,627
-93,061
-5% -$2M 0.01% 1198
2023
Q3
$40.5M Sell
1,963,688
-26,019
-1% -$537K 0.01% 1130
2023
Q2
$58.7M Sell
1,989,707
-26,916
-1% -$794K 0.01% 916
2023
Q1
$46.5M Buy
2,016,623
+10,703
+0.5% +$247K 0.01% 1053
2022
Q4
$55.8M Buy
2,005,920
+110,628
+6% +$3.08M 0.01% 915
2022
Q3
$58.2M Buy
1,895,292
+27,162
+1% +$834K 0.01% 866
2022
Q2
$55M Buy
1,868,130
+258,913
+16% +$7.62M 0.01% 922
2022
Q1
$51.8M Buy
1,609,217
+676,625
+73% +$21.8M 0.01% 1070
2021
Q4
$41.6M Buy
932,592
+555,873
+148% +$24.8M 0.01% 1282
2021
Q3
$19M Buy
376,719
+29,350
+8% +$1.48M ﹤0.01% 1749
2021
Q2
$27.2M Buy
347,369
+86,005
+33% +$6.75M 0.01% 1559
2021
Q1
$14.9M Sell
261,364
-178,006
-41% -$10.2M ﹤0.01% 1871
2020
Q4
$36.8M Sell
439,370
-288,839
-40% -$24.2M 0.01% 1247
2020
Q3
$26.1M Buy
728,209
+82,247
+13% +$2.95M 0.01% 1298
2020
Q2
$15.6M Buy
645,962
+302,215
+88% +$7.31M ﹤0.01% 1590
2020
Q1
$6.02M Buy
343,747
+7,517
+2% +$132K ﹤0.01% 1982
2019
Q4
$5.86M Sell
336,230
-2,687
-0.8% -$46.8K ﹤0.01% 2254
2019
Q3
$5.19M Buy
338,917
+111,897
+49% +$1.71M ﹤0.01% 2263
2019
Q2
$4.71M Sell
227,020
-1,154
-0.5% -$24K ﹤0.01% 2360
2019
Q1
$5.3M Buy
228,174
+669
+0.3% +$15.5K ﹤0.01% 2307
2018
Q4
$4.7M Buy
227,505
+23,809
+12% +$492K ﹤0.01% 2335
2018
Q3
$4.43M Buy
203,696
+142,500
+233% +$3.1M ﹤0.01% 2462
2018
Q2
$933K Buy
61,196
+8,882
+17% +$135K ﹤0.01% 3281
2018
Q1
$1.03M Buy
+52,314
New +$1.03M ﹤0.01% 3196